SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-054848
Filing Date
2022-05-02
Accepted
2022-05-02 18:38:41
Documents
2
Period of Report
2022-04-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2214262-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2214262-1_3seq1.xml 3 1621
2 POWER OF ATTORNEY tm2214262d1_ex24-1.htm EX-24.1 10127
  Complete submission text file 0001104659-22-054848.txt   13265
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 630 W. GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address
Drexler Susan L. (Reporting) CIK: 0001821287 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36672 | Film No.: 22883760